Finally, in vivo experiments were allowed to investigate whether FKC treatment regulates proliferation, glycolysis, and angiogenesis of NPC cells by HSP90B1/EGFR pathway. The gene discussed is HSP90B1; the disease is nasopharyngeal carcinoma.